Related Experiment Videos
Fibroblasts, glial, and neuronal cells are involved in extravascular prothrombin activation
Y Yamazaki1, Y Shikamoto, K Fukudome
1Department of Biochemistry, Meiji Pharmaceutical University, Noshio, Kiyose, Tokyo, 204-8588, Japan.
Abstract:
A membrane-associated prothrombin activator (MAPA) was found on various cultured cells derived from non-hematopoietic cells [Sekiya, F. et al. (1994) J. Biol. Chem. 269, 32441-32445]. In this study, we investigated the enzymatic properties of this enzyme using protease inhibitors. While the metalloproteinase inhibitor, o-phenanthroline, had no effect, some Kunitz type serine protease inhibitors attenuated MAPA activity. Recombinant tissue factor pathway inhibitor (rTFPI) also markedly reduced the activity (IC(50), 1. 3+/-0.6 x 10(-10) M). MAPA activity is, therefore, most likely to be due to factor Xa. We evaluated the effect of exogenous factor Xa on MAPA activity. Factor Xa-dependent prothrombin activation was observed on fibroblast cells (apparent K(d), 1.47+/-0.72 nM). Activation was also observed on glial and neuronal cells, which expressed MAPA activity. These results imply that membrane-bound factor Xa results in MAPA activity on these cells. Therefore, we considered the involvement of factor Va, a component of prothrombinase, in this activity. We examined whether or not the prothrombinase complex is assembled on these cells. Prothrombin was activated in a manner dependent on both exogenous factor Xa and factor Va (apparent K(d) of 0.51-1.81 nM for factor Va). These results indicate that the prothrombinase complex forms specifically on various extravascular cells. Although the prothrombinase complex can be assembled on monocytes and lymphocytes, it is not known why these cells can activate prothrombin specifically. These cells which have the capacity for prothrombin activator activity could also activate factor X; i.e. cells with factor X activation activity were able to convert prothrombin. These observations suggest that thrombin was generated via two procoagulant activities; factor X activation and subsequent prothrombinase complex formation on the surface of these cells. This mechanism may explain the various pathological states involving or resulting from extravascular thrombin and fibrin formation.
Insights
Extravascular cells activate prothrombin via membrane-associated prothrombin activator (MAPA) activity, likely involving factor Xa and factor Va forming a prothrombinase complex. This mechanism may explain pathological thrombin generation outside blood vessels.
Area of Science:
- Biochemistry
- Cell Biology
- Hematology
Background:
- Membrane-associated prothrombin activator (MAPA) activity has been identified on various cultured non-hematopoietic cells.
- The precise enzymatic nature and mechanism of MAPA activity on these cells remain to be fully elucidated.
Purpose of the Study:
- To investigate the enzymatic properties of MAPA using protease inhibitors.
- To determine the role of factor Xa and factor Va in MAPA activity.
- To explore the assembly of the prothrombinase complex on extravascular cells.
Main Methods:
- Enzymatic assays using protease inhibitors and recombinant tissue factor pathway inhibitor (rTFPI).
- Evaluation of exogenous factor Xa and factor Va effects on prothrombin activation.
- Assessment of prothrombinase complex formation on various cell types.
Main Results:
- MAPA activity was inhibited by Kunitz-type serine protease inhibitors and rTFPI, suggesting involvement of factor Xa.
- Factor Xa-dependent prothrombin activation was observed on fibroblast, glial, and neuronal cells.
- The prothrombinase complex, comprising factor Xa and factor Va, was shown to assemble on these extravascular cells, leading to thrombin generation.
Conclusions:
- MAPA activity on extravascular cells is attributed to membrane-bound factor Xa and the subsequent assembly of the prothrombinase complex.
- This cell-surface prothrombinase complex formation on extravascular cells represents a novel pathway for thrombin generation.
- This mechanism may contribute to pathological thrombin and fibrin formation in various disease states.